XASX
MPL
Market cap10bUSD
Aug 03, Last price
5.18AUD
1D
0.19%
1Q
11.40%
Jan 2017
83.69%
IPO
146.67%
Name
Medibank Private Ltd
Chart & performance
P/E
28.49
P/S
1.67
EPS
0.18
Div yield, %
4.99%
Shrs. gr., 5y
—
Rev. gr., 5y
4.60%
Revenues
8.56b
+6.71%
Net income
501m
+1.69%
CFO
381m
-56.14%
Dividend
Feb 25, 20260.083 AUD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Medibank Private Limited is an Australian firm specializing in private health insurance and health-related services. The company's operations are divided into two principal segments: Health Insurance and Medibank Health. The Health Insurance division offers a variety of private health insurance policies, including hospital coverage for treatments and ancillary coverage for services such as dental, optical, and physiotherapy. It also caters to overseas visitors and students with specific health insurance products. These policies are underwritten using the Medibank and ahm brands. The Medibank Health segment provides health management, in-home care, and various telehealth services to government and corporate entities. Furthermore, this segment distributes travel, life, and pet insurance products. Medibank Private Limited was established in 1976 and is headquartered in Docklands, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||